BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Estell EG, Rosen CJ. Emerging insights into the comparative effectiveness of anabolic therapies for osteoporosis. Nat Rev Endocrinol 2021;17:31-46. [PMID: 33149262 DOI: 10.1038/s41574-020-00426-5] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 16.0] [Reference Citation Analysis]
Number Citing Articles
1 Tian S, Zou Y, Wang J, Li Y, An BZ, Liu YQ. Protective effect of Du-Zhong-Wan against osteoporotic fracture by targeting the osteoblastogenesis and angiogenesis couple factor SLIT3. J Ethnopharmacol 2022;295:115399. [PMID: 35649495 DOI: 10.1016/j.jep.2022.115399] [Reference Citation Analysis]
2 Que Y, Yang Y, Zafar H, Wang D. Tetracycline-grafted mPEG-PLGA micelles for bone-targeting and osteoporotic improvement. Front Pharmacol 2022;13:993095. [DOI: 10.3389/fphar.2022.993095] [Reference Citation Analysis]
3 Aurora R, Veis D. Does Aging Activate T-cells to Reduce Bone Mass and Quality? Curr Osteoporos Rep 2022. [PMID: 36044177 DOI: 10.1007/s11914-022-00745-8] [Reference Citation Analysis]
4 Tirado‐cabrera I, Martin‐guerrero E, Heredero‐jimenez S, Ardura JA, Gortázar AR. PTH1R translocation to primary cilia in mechanically‐stimulated ostecytes prevents osteoclast formation via regulation of CXCL5 and IL‐6 secretion. Journal Cellular Physiology. [DOI: 10.1002/jcp.30849] [Reference Citation Analysis]
5 Wang C, Li F, Li Y, Feng H, Zhao MW, Tu PF, Tian H. Cistanche Deserticola for Regulation of Bone Metabolism: Therapeutic Potential and Molecular Mechanisms on Postmenopausal Osteoporosis. Chin J Integr Med 2022. [PMID: 35930138 DOI: 10.1007/s11655-022-3518-z] [Reference Citation Analysis]
6 Niu Y, Yang Y, Yang Z, Wang X, Zhang P, Lv L, Liu Y, Liu Y, Zhou Y. Aptamer-immobilized bone-targeting nanoparticles in situ reduce sclerostin for osteoporosis treatment. Nano Today 2022;45:101529. [DOI: 10.1016/j.nantod.2022.101529] [Reference Citation Analysis]
7 Zheng L, Zhuang Z, Li Y, Shi T, Fu K, Yan W, Zhang L, Wang P, Li L, Jiang Q. Bone targeting antioxidative nano-iron oxide for treating postmenopausal osteoporosis. Bioactive Materials 2022;14:250-61. [DOI: 10.1016/j.bioactmat.2021.11.012] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
8 Vogler M, Oleksy A, Schulze S, Fedorova M, Kojonazarov B, Nijjar S, Patel S, Jossi S, Sawmynaden K, Henry M, Brown R, Matthews D, Offermanns S, Worzfeld T. An antagonistic monoclonal anti-Plexin-B1 antibody exerts therapeutic effects in mouse models of postmenopausal osteoporosis and multiple sclerosis. J Biol Chem 2022;:102265. [PMID: 35850304 DOI: 10.1016/j.jbc.2022.102265] [Reference Citation Analysis]
9 Rana D, Salave S, Jain S, Shah R, Benival D. Systematic Development and Optimization of Teriparatide-Loaded Nanoliposomes Employing Quality by Design Approach for Osteoporosis. J Pharm Innov. [DOI: 10.1007/s12247-022-09663-9] [Reference Citation Analysis]
10 Chen Y, Wang X, Zhang C, Liu Z, Li C, Ren Z. Gut Microbiota and Bone Diseases: A Growing Partnership. Front Microbiol 2022;13:877776. [DOI: 10.3389/fmicb.2022.877776] [Reference Citation Analysis]
11 Cui J, Shibata Y, Zhu T, Zhou J, Zhang J. Osteocytes in bone aging: Advances, challenges, and future perspectives. Ageing Res Rev 2022;77:101608. [PMID: 35283289 DOI: 10.1016/j.arr.2022.101608] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
12 Xu J, Ye Z, Chen C, Zhang X, Han K, Wu X, Li Z, Jiang J, Yan X, Cai J, Zhao J. Abaloparatide Improves Rotator Cuff Healing via Anabolic Effects on Bone Remodeling in a Chronic Rotator Cuff Tear Model of Rat With Osteoporosis: A Comparison With Denosumab. Am J Sports Med 2022;:3635465221079651. [PMID: 35404150 DOI: 10.1177/03635465221079651] [Reference Citation Analysis]
13 Zhu S, Pang Y, Xu J, Chen X, Zhang C, Wu B, Gao J. Endocrine Regulation on Bone by Thyroid. Front Endocrinol 2022;13:873820. [DOI: 10.3389/fendo.2022.873820] [Reference Citation Analysis]
14 Curtis EM, Reginster JY, Al-Daghri N, Biver E, Brandi ML, Cavalier E, Hadji P, Halbout P, Harvey NC, Hiligsmann M, Javaid MK, Kanis JA, Kaufman JM, Lamy O, Matijevic R, Perez AD, Radermecker RP, Rosa MM, Thomas T, Thomasius F, Vlaskovska M, Rizzoli R, Cooper C. Management of patients at very high risk of osteoporotic fractures through sequential treatments. Aging Clin Exp Res 2022;34:695-714. [PMID: 35332506 DOI: 10.1007/s40520-022-02100-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
15 Khera TK, Hunt LP, Davis S, Gooberman-Hill R, Thom H, Xu Y, Paskins Z, Peters TJ, Tobias JH, Clark EM. A clinical tool to identify older women with back pain at high risk of osteoporotic vertebral fractures (Vfrac): a population-based cohort study with exploratory economic evaluation. Age Ageing 2022;51:afac031. [PMID: 35284926 DOI: 10.1093/ageing/afac031] [Reference Citation Analysis]
16 Xu X, Li Y, Shi L, He K, Sun Y, Ding Y, Meng B, Zhang J, Xiang L, Dong J, Liu M, Zhang J, Xiang L, Xiang G. Myeloid-derived growth factor (MYDGF) protects bone mass through inhibiting osteoclastogenesis and promoting osteoblast differentiation. EMBO Rep 2022;23:e53509. [PMID: 35068044 DOI: 10.15252/embr.202153509] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
17 Abdurahman A, Li X, Li J, Liu D, Zhai L, Wang X, Zhang Y, Meng Y, Yokota H, Zhang P. Loading-driven PI3K/Akt signaling and erythropoiesis enhanced angiogenesis and osteogenesis in a postmenopausal osteoporosis mouse model. Bone 2022;:116346. [PMID: 35114427 DOI: 10.1016/j.bone.2022.116346] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Li H, Xiao W, He Y, Wen Z, Cheng S, Zhang Y, Li Y. Novel Insights Into the Multifaceted Functions of RNA n6-Methyladenosine Modification in Degenerative Musculoskeletal Diseases. Front Cell Dev Biol 2021;9:766020. [PMID: 35024366 DOI: 10.3389/fcell.2021.766020] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
19 Fang Y, Liu Y, Zhao Z, Lu Y, Shen X, Zhu T, Hou M, He F, Yang H, Zhang Y, Shi Q, Zhu X. Bortezomib Rescues Ovariectomy-Induced Bone Loss via SMURF-Mediated Ubiquitination Pathway. Oxid Med Cell Longev 2021;2021:9661200. [PMID: 35003523 DOI: 10.1155/2021/9661200] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Ma X, Tian Y, Xue K, Huai Y, Patil S, Deng X, Hao Q, Li D, Miao Z, Zhang W, Qian A. Kaempferide enhances antioxidant capacity to promote osteogenesis through FoxO1/β-catenin signaling pathway. Eur J Pharmacol 2021;911:174555. [PMID: 34627807 DOI: 10.1016/j.ejphar.2021.174555] [Reference Citation Analysis]
21 Yang C, Yang P, Liu P, Wang H, Ke E, Li K, Yan H. Targeting Filamin A alleviates ovariectomy-induced bone loss in mice via the WNT/β-catenin signaling pathway. Cell Signal 2021;90:110191. [PMID: 34774991 DOI: 10.1016/j.cellsig.2021.110191] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
22 Gong W, Chen X, Shi T, Shao X, An X, Qin J, Chen X, Jiang Q, Guo B. Network Pharmacology-Based Strategy for the Investigation of the Anti-Osteoporosis Effects and Underlying Mechanism of Zhuangguguanjie Formulation. Front Pharmacol 2021;12:727808. [PMID: 34658868 DOI: 10.3389/fphar.2021.727808] [Reference Citation Analysis]
23 Kim B, Cho YJ, Lim W. Osteoporosis therapies and their mechanisms of action (Review). Exp Ther Med 2021;22:1379. [PMID: 34650627 DOI: 10.3892/etm.2021.10815] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
24 Xu J, Hu P, Zhang X, Chen J, Wang J, Zhang J, Chen Z, Yu MK, Chung YW, Wang Y, Zhang X, Zhang Y, Zheng N, Yao H, Yue J, Chan HC, Qin L, Ruan YC. Magnesium implantation or supplementation ameliorates bone disorder in CFTR-mutant mice through an ATF4-dependent Wnt/β-catenin signaling. Bioact Mater 2022;8:95-108. [PMID: 34541389 DOI: 10.1016/j.bioactmat.2021.06.034] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
25 Wu RW, Lian WS, Chen YS, Ko JY, Wang SY, Jahr H, Wang FS. Piezoelectric Microvibration Mitigates Estrogen Loss-Induced Osteoporosis and Promotes Piezo1, MicroRNA-29a, and Wnt3a Signaling in Osteoblasts. Int J Mol Sci 2021;22:9476. [PMID: 34502380 DOI: 10.3390/ijms22179476] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
26 Wang FS, Wu RW, Chen YS, Ko JY, Jahr H, Lian WS. Biophysical Modulation of the Mitochondrial Metabolism and Redox in Bone Homeostasis and Osteoporosis: How Biophysics Converts into Bioenergetics. Antioxidants (Basel) 2021;10:1394. [PMID: 34573026 DOI: 10.3390/antiox10091394] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
27 Lee CC, Hung CM, Chen CH, Hsu YC, Huang YP, Huang TB, Lee MJ. Novel Aptamer-Based Small-Molecule Drug Screening Assay to Identify Potential Sclerostin Inhibitors against Osteoporosis. Int J Mol Sci 2021;22:8320. [PMID: 34361085 DOI: 10.3390/ijms22158320] [Reference Citation Analysis]
28 Li SS, He SH, Xie PY, Li W, Zhang XX, Li TF, Li DF. Recent Progresses in the Treatment of Osteoporosis. Front Pharmacol 2021;12:717065. [PMID: 34366868 DOI: 10.3389/fphar.2021.717065] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
29 Lu L, Chen X, Liu Y, Yu X. Gut microbiota and bone metabolism. FASEB J 2021;35:e21740. [PMID: 34143911 DOI: 10.1096/fj.202100451R] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
30 Tang CC, Castro Andrade CD, O'Meara MJ, Yoon SH, Sato T, Brooks DJ, Bouxsein ML, Martins JDS, Wang J, Gray NS, Misof B, Roschger P, Blouin S, Klaushofer K, Velduis-Vlug A, Vegting Y, Rosen CJ, O'Connell D, Sundberg TB, Xavier RJ, Ung P, Schlessinger A, Kronenberg HM, Berdeaux R, Foretz M, Wein MN. Dual targeting of salt inducible kinases and CSF1R uncouples bone formation and bone resorption. Elife 2021;10:e67772. [PMID: 34160349 DOI: 10.7554/eLife.67772] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
31 Zhang YW, Lu PP, Li YJ, Dai GC, Cao MM, Xie T, Zhang C, Shi L, Rui YF. Low dietary choline intake is associated with the risk of osteoporosis in elderly individuals: a population-based study. Food Funct 2021;12:6442-51. [PMID: 34076003 DOI: 10.1039/d1fo00825k] [Reference Citation Analysis]
32 Jin ZX, Liao XY, Da WW, Zhao YJ, Li XF, Tang DZ. Osthole enhances the bone mass of senile osteoporosis and stimulates the expression of osteoprotegerin by activating β-catenin signaling. Stem Cell Res Ther 2021;12:154. [PMID: 33640026 DOI: 10.1186/s13287-021-02228-6] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
33 Zhang S, Zhang Y, Fang Y, Chen H, Hao M, Tan Q, Hu C, Zhou H, Xu J, Gu Q. Synthesis and evaluation of andrographolide derivatives as potent anti-osteoporosis agents in vitro and in vivo. Eur J Med Chem 2021;213:113185. [PMID: 33485256 DOI: 10.1016/j.ejmech.2021.113185] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]